SCHEMBL21798465

SCHEMBL21798465

Cc1ccccc1C(=O)[Ge](C(=O)c1ccccc1C)(C(=O)c1ccccc1C)C(=O)c1ccccc1C

nearest known ligand 0.60

Predicted protein targets (top 16)

geneUniProtsupporting neighboursconfidence
▸ HPGD P15428 3/20 0.48
▸ TYK2 P29597 1/20 0.47
▸ ERCC5 P28715 1/20 0.47
▸ FEN1 P39748 1/20 0.47
▸ L3MBTL1 Q9Y468 1/20 0.46
▸ HTT P42858 1/20 0.46
▸ CTNNB1 P35222 1/20 0.44
▸ WNT3A P56704 1/20 0.44
▸ SMN1; SMN2 Q16637 1/20 0.44
▸ MYC P01106 1/20 0.44
▸ KDM4E B2RXH2 1/20 0.43
▸ ALDH1A1 P00352 1/20 0.43
▸ HSD17B10 Q99714 1/20 0.43
▸ MAPK1 P28482 1/20 0.43
▸ POLB P06746 1/20 0.43
▸ KMT2A Q03164 1/20 0.43

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL21812133 0.90 NPC1 (0.46) HPGDTYK2ERCC5FEN1L3MBTL1
SCHEMBL195140 0.78 HPGD (0.50) HPGDTYK2ERCC5FEN1HTT
SCHEMBL333141 0.77 CYP3A4 (0.55) HPGDERCC5FEN1HTTSMN1; SMN2
SCHEMBL29387256 0.77 CYP3A4 (0.55) HPGDERCC5FEN1HTTSMN1; SMN2
SCHEMBL166603 0.77 HPGD (0.54) HPGDERCC5FEN1HTTSMN1; SMN2
SCHEMBL29425530 0.77 HPGD (0.54) HPGDERCC5FEN1HTTSMN1; SMN2
SCHEMBL49951 0.75 HPGD (0.52) HPGDERCC5FEN1HTTSMN1; SMN2
Toluic Acid SCHEMBL6571818 0.75 ALDH1A1 (0.65) HPGDERCC5FEN1SMN1; SMN2MYC
SCHEMBL10669335 0.75 CYP3A4 (0.59) HPGDERCC5FEN1HTTSMN1; SMN2
Toluic Acid SCHEMBL148201 0.75 ALDH1A1 (0.65) HPGDERCC5FEN1SMN1; SMN2MYC

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 92 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-4656661-A1 BLOCK COPOLYMERS SUITABLE AS IMPACT MODIFIERS, PROCESS FOR THEIR PREPARATION AND POLYMERIZABLE MATERIALS COMPRISING THEM Ivoclar Vivadent AG (LI) 2025-12-03 — — EP claimed
EP-4085893-B1 TRANSPARENT, FRACTURE-RESISTANT POLYMERISATION RESINS FOR THE PRODUCTION OF DENTAL MOULDINGS IVOCLAR VIVADENT AG (LI) 2025-02-26 — — EP claimed
US-11998621-B2 Transparent, fracture-tough polymerization resins for the production of dental shaped bodies IVOCLAR VIVADENT AG (LI) 2024-06-04 — — US claimed
CN-111228124-B Rapidly curing and low shrinkage stress photopolymerizable dental composites 义获嘉伟瓦登特公司 2024-04-09 — — CN claimed
US-11673980-B2 Photopolymerizable dental composites with rapid curing and low shrinkage stress IVOCLAR VIVADENT AG (LI) 2023-06-13 — — US claimed
US-20220370300-A1 Transparent, Fracture-Tough Polymerization Resins For The Production Of Dental Shaped Bodies IVOCLAR VIVADENT AG (LI) 2022-11-24 — — US claimed
EP-4085893-A1 TRANSPARENT, FRACTURE-RESISTANT POLYMERISATION RESINS FOR THE PRODUCTION OF DENTAL MOULDINGS Ivoclar Vivadent AG (LI) 2022-11-09 — — EP claimed
CN-115300400-A Transparent, fracture-tough polymeric resins for the production of dental molded bodies 义获嘉伟瓦登特公司 2022-11-08 — — CN claimed
EP-3659575-A1 PHOTOPOLYMERISABLE DENTAL COMPOSITES WITH FAST CURING AND LOW SHRINKAGE STRESS Ivoclar Vivadent AG (LI) 2020-06-03 — — EP claimed
US-20200165363-A1 PHOTOPOLYMERIZABLE DENTAL COMPOSITES WITH RAPID CURING AND LOW SHRINKAGE STRESS IVOCLAR VIVADENT AG (LI) 2020-05-28 — — US claimed
US-20260132235-A1 2-Component Dental Materials Based On Crosslinked Polymeric Particles Bearing Acylthiourea Groups IVOCLAR VIVADENT AG (LI) 2026-05-14 — — US disclosed
EP-4656661-A1 BLOCK COPOLYMERS SUITABLE AS IMPACT MODIFIERS, PROCESS FOR THEIR PREPARATION AND POLYMERIZABLE MATERIALS COMPRISING THEM Ivoclar Vivadent AG (LI) 2025-12-03 — — EP disclosed
EP-4591847-A1 2-COMPONENT DENTAL MATERIALS BASED ON CROSSLINKED POLYMERIC PARTICLES BEARING ACYLTHIOUREA GROUPS Ivoclar Vivadent AG (LI) 2025-07-30 — — EP disclosed
US-12357440-B2 Container for producing a dental synthetic material composition IVOCLAR VIVADENT AG (LI) 2025-07-15 — — US disclosed
EP-4085893-B1 TRANSPARENT, FRACTURE-RESISTANT POLYMERISATION RESINS FOR THE PRODUCTION OF DENTAL MOULDINGS IVOCLAR VIVADENT AG (LI) 2025-02-26 — — EP disclosed
US-20200165363-A1 PHOTOPOLYMERIZABLE DENTAL COMPOSITES WITH RAPID CURING AND LOW SHRINKAGE STRESS IVOCLAR VIVADENT AG (LI) 2020-05-28 — — US disclosed
US-20200087241-A1 Polymer Materials With Unsaturated Transfer Reagents IVOCLAR VIVADENT AG (LI) 2020-03-19 — — US disclosed
EP-3622942-A1 POLYMERIC MATERIALS WITH UNSATURATED TRANSMISSION REAGENTS Ivoclar Vivadent AG (LI) 2020-03-18 — — EP disclosed
EP-3622943-A1 POLYMERISABLE MATERIALS BASED ON DIMERISATION-CAPABLE BENZALDEHYDE DERIVATIVES Ivoclar Vivadent AG (LI) 2020-03-18 — — EP disclosed
US-20200079888-A1 Polymerizable Materials Based On Dimerizable Benzaldehyde Derivatives IVOCLAR VIVADENT AG (LI) 2020-03-12 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (7 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20260132235-A1 2-Component Dental Materials Based On Crosslinked Polymeric Particles Bearing Acylthiourea Groups HBG1, TCP1, GSTM1 HPGD 1080/4885TYK2 2433/4885ERCC5 1736/4885
US-11998621-B2 Transparent, fracture-tough polymerization resins for the production of dental shaped bodies MMAB, VCL, BOLA2; BOLA2B HPGD 3105/4885TYK2 558/4885ERCC5 908/4885
US-20220370300-A1 Transparent, Fracture-Tough Polymerization Resins For The Production Of Dental Shaped Bodies MMAB, VCL, BOLA2; BOLA2B HPGD 3105/4885TYK2 558/4885ERCC5 908/4885
US-11673980-B2 Photopolymerizable dental composites with rapid curing and low shrinkage stress MMAB, ALAD, SULT1E1 HPGD 1816/4885TYK2 1525/4885ERCC5 1569/4885
US-20200087241-A1 Polymer Materials With Unsaturated Transfer Reagents C1S, C1R, PYM1 HPGD 644/4885TYK2 3593/4885ERCC5 3148/4885
US-20200165363-A1 PHOTOPOLYMERIZABLE DENTAL COMPOSITES WITH RAPID CURING AND LOW SHRINKAGE STRESS MMAB, ALAD, SULT1E1 HPGD 1816/4885TYK2 1525/4885ERCC5 1569/4885
US-20200079888-A1 Polymerizable Materials Based On Dimerizable Benzaldehyde Derivatives FANCI, CAD, ALDH1A2 HPGD 151/4885TYK2 3001/4885ERCC5 122/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback